1. Home
  2. TALO vs MIRM Comparison

TALO vs MIRM Comparison

Compare TALO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALO
  • MIRM
  • Stock Information
  • Founded
  • TALO 2011
  • MIRM 2018
  • Country
  • TALO United States
  • MIRM United States
  • Employees
  • TALO N/A
  • MIRM N/A
  • Industry
  • TALO Oil & Gas Production
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TALO Energy
  • MIRM Health Care
  • Exchange
  • TALO Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • TALO 1.8B
  • MIRM 1.9B
  • IPO Year
  • TALO N/A
  • MIRM 2019
  • Fundamental
  • Price
  • TALO $11.78
  • MIRM $42.00
  • Analyst Decision
  • TALO Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • TALO 10
  • MIRM 13
  • Target Price
  • TALO $18.25
  • MIRM $56.23
  • AVG Volume (30 Days)
  • TALO 1.9M
  • MIRM 278.8K
  • Earning Date
  • TALO 11-11-2024
  • MIRM 11-15-2024
  • Dividend Yield
  • TALO N/A
  • MIRM N/A
  • EPS Growth
  • TALO N/A
  • MIRM N/A
  • EPS
  • TALO N/A
  • MIRM N/A
  • Revenue
  • TALO $1,744,933,000.00
  • MIRM $264,375,999.00
  • Revenue This Year
  • TALO $37.97
  • MIRM $73.07
  • Revenue Next Year
  • TALO $0.55
  • MIRM $27.98
  • P/E Ratio
  • TALO N/A
  • MIRM N/A
  • Revenue Growth
  • TALO 24.09
  • MIRM 128.34
  • 52 Week Low
  • TALO $9.44
  • MIRM $23.14
  • 52 Week High
  • TALO $15.17
  • MIRM $45.23
  • Technical
  • Relative Strength Index (RSI)
  • TALO 67.27
  • MIRM 63.67
  • Support Level
  • TALO $10.01
  • MIRM $40.61
  • Resistance Level
  • TALO $10.48
  • MIRM $42.75
  • Average True Range (ATR)
  • TALO 0.43
  • MIRM 1.49
  • MACD
  • TALO 0.22
  • MIRM 0.31
  • Stochastic Oscillator
  • TALO 97.15
  • MIRM 83.70

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: